{"nct_id":"NCT03439293","title":"A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)","status":"COMPLETED","status_verified_date":"2024-06","start_date":"2018-03-13","start_date_type":"ACTUAL","primary_completion_date":"2022-01-01","primary_completion_date_type":"ACTUAL","completion_date":"2023-06-26","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}